Vitamin D deficiency and insufficiency among patients with prostate cancer

BJU International

Volumn 104, Issue 7, 2009, Pages 909-914

  Trump, Donald L ^a,b,c   Chadha, Manpreet K ^b   Sunga, Annette Y ^b   Fakih, Marwan G ^b,c   Ashraf, Umeer ^b   Silliman, Carrie G ^b   Hollis, Bruce W ^d   Nesline, Mary K ^c   Tian, Lili ^c   Tan, Wei ^c   Johnson, Candace S ^c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

25 hydroxy vitamin D; Deficiency; Prostate cancer; Season

Indexed keywords

VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; VITAMIN D DEFICIENCY; BLOOD; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; PROSTATE TUMOR; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 70049099479     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08531.x     Document Type: Article

References (55)

1. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006 81 : 353 373
2. Holick M. Vitamin D deficiency. N Engl J Med 2007 357 : 266 281
3. Chapuy MC, Preziosi P, Maamer M et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997 7 : 439 443
4. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008 87 : 1080S 1086S
5. Nesby-O'Dell S, Scanlon KS, Cogswell ME et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age. Third National Health and Nutrition Examination Survey, 1988-94. Am J Clin Nutr 2002 76 : 187 192
6. Lips P, Hosking D, Lippuner K et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006 260 : 245 254
7. Thomas MK, Lloyd-Jones DM, Thadhani RI et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998 338 : 777 783
8. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989 2 : 1176 1178
9. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality: evidence for a protective effect of ultraviolet radiation. Cancer 1992 70 : 2861 2869
10. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980 9 : 227 231
11. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000 11 : 847 852
12. Giovannucci E, Liu Y, Rimm EB et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006 98 : 451 459
13. Zhou W, Heist RS, Liu G et al. Circulating 25-hydroxyvitamin d levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007 25 : 479 485
14. Grant WB. An estimate of premature cancer mortality in the U.S: due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002 94 : 1867 1875
15. Manuel Quesada J, Solana R, Serrano I et al. Immunologic effects of vitamin D. N Engl J Med 1989 321 : 833 834
16. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008 4 : 80 90
17. Beer TM, Ryan CW, Venner PM et al. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators. J Clin Oncol 2007 25 : 669 674
18. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel D. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007 55 : 234 239
19. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003 78 : 1463 1470
20. Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength an muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab 2003 88 : 5766 5772
21. Tangpricha V, Colon NA, Kaul H et al. Prevalence of vitamin D deficiency in patients attending an outpatient cancer care clinic in Boston. Endocr Pract 2004 10 : 292 293
22. Everett PC. The prevalence of vitamin D deficiency and insufficiency in a hematology-oncology clinic. Clin J Oncol Nurs 2008 12 : 33 5
23. 125I-labeled tracer. Clin Chem 1993 39 : 529 533
24. Ersfeld DL, Rao DS, Body J et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 2004 37 : 867 874
25. Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, Sunga AY. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis 2009 24 : 219 224
26. Li H, Stampfer MJ, Hollis JB et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. Plos Med 2007 4 : e103
27. Adler RA. Cancer treatment-induced bone loss. Curr Opin Endocrinol Diabetes Obes 2007 14 : 442 445
28. Hoff AO, Gagel RF. Osteoporosis in breast and prostate cancer survivors. Oncology (Williston Park) 2005 19 : 651 658
29. Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist 2006 11 : 1121 1131
30. Morote J, Morin JP, Orsola A et al. Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer. Urology 2007 69 : 500 504
31. Greenspan SL, Coates P, Sereika SM et al. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 2005 90 : 6410 6417
32. Beer TM, Venner PM, Ryan CW et al. High dose calcitriol may reduce thrombosis in cancer patients. Br J Haematol 2006 135 : 392 394
33. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin d-mediated human antimicrobial response. Science 2006 311 : 1770 1773
34. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin d-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007 179 : 2060 2063
35. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007 103 : 793 798
36. Martineau AR, Wilkinson RJ, Wilkinson KA et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007 176 : 208 213
37. Endo I, Inoue D, Mitsui T et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003 144 : 5138 5144
38. Bischoff HA, Stähelin HB, Dick W et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003 18 : 343 351
39. Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 2007 103 : 521 524
40. Mantell DJ, Owens PE, Bundred NJ et al. 1,25-Dihydroxyvitamin D (3) inhibits angiogenesis in vitro and in vivo. Circ Res 2000 87 : 214 220
41. Doetsch AM, Faber J, Lynnerup N et al. The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo-controlled study. Calcif Tissue Int 2004 75 : 183 188
42. Chung I, Wong MK, Flynn G et al. Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells. Cancer Res 2006 66 : 8565 8573
43. Amson Y, Amital H, Schoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007 66 : 1137 1142
44. Munger KL, Levin LI, Hollis BW et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006 296 : 2832 2838
45. Munger KL, Zhang SM, O'Reilly E et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004 62 : 60 5
46. Garcion E, Sindji L, Nataf S et al. Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol 2003 105 : 438 448
47. Pedersen LB, Nashold FE, Spach KM, Hayes CE. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res 2007 85 : 2480 2490
48. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine. Vitamin D. In Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC : National Academy Press, 1999 : 250 287
49. Glerup H, Mikkelsen K, Poulsen L et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000 247 : 260 268
50. Chapuy MC, Preziosi P, Maaner M et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis Int 1997 7 : 439 443
51. 3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004 89-90 : 575 579
52. Bischoff-Ferrari HA, Giovannucci E, Willett WC et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006 84 : 18 28
53. Woo TC, Choo R, Jamieson M et al. Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr Cancer 2005 51 : 32 6
54. Gross C, Stamey T, Hancock S, Feldman D. Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). J Urol 1998 159 : 2035 2039
55. Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS. Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer. Cancer 2006 106 : 2136 2142